Skip to content

BiPAP AVAPS BiPAP AVAPS C Series Core Pack, 30cm, CNRecalls & reported problems

Respironics, Inc. · BiPAP AVAPS C Series Core Package, China · Class 2

All models of BiPAP AVAPS (13)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00606959015777), received between Jun 16, 2021 and Sep 23, 2026 — classified as 1 death, 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Degraded” (3 reports).

1 other recall cover devices cleared under the same FDA submission (K102465); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Degraded3
  • Failure to Power Up1
  • Mechanical Problem1

Patient problems

  • Dyspnea2
  • No Clinical Signs, Symptoms or Conditions2
  • Cyanosis1
  • Insufficient Information1
  • Pallor1
  • Unspecified Mental, Emotional or Behavioral Problem1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 23, 2026Degraded

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50863070 ↗
  • MalfunctionOct 18, 2024Degraded; Degraded

    THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION ALLEGING SHORTNESS OF BREATH TO WORSEN. MEDICAL INTERVENTION WAS NOT SPECIFIED. NO ADDITIONAL INFORMATION CAN BE REQUESTED AT THIS TIME. THE MANUFACTURER WAS MADE AWARE OF THIS COMPLAINT THROUGH A REPRESENTATIVE OF THE CUSTOMER. AT THIS TIME, NO FURTHER INVESTIGATION CAN BE PERFORMED. IF ANY ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW UP REPORT WILL BE FILED.

    Patient problems: Dyspnea

    MAUDE report 20482790 ↗
  • MalfunctionJan 3, 2024Degraded; Degraded

    THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION ALLEGING VISUALIZATION OF PARTICLES IN THE AIR PATH. THERE IS NO ALLEGATION OF SERIOUS OR PERMANENT HARM OR INJURY. NO MEDICAL INTERVENTION WAS REQUIRED BY THE PATIENT. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18441093 ↗
  • InjuryJun 30, 2023Failure to Power Up; Failure to Power Up

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING A BIPAP AVAPS C-SERIES DEVICE WAS NOT OPERATING PROPERLY AND THE HOST DOES NOT RUN WHEN THE NON-INVASIVE VENTILATOR IS TURNED ON. THE PATIENT SYMPTOMS INCLUDE, "CLEAR, MENTALLY POOR, SHORTNESS OF BREATH, AND CYANOSIS OF THE LIPS, BREATHING 26/MIN, SPO2 88%,." THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

    Patient problems: Cyanosis; Dyspnea; Pallor; Unspecified Mental, Emotional or Behavioral Problem

    MAUDE report 17241871 ↗
  • DeathJun 16, 2021Mechanical Problem; Mechanical Problem

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING A BIPAP AVAPS CSERIES DEVICE WAS NOT OPERATING PROPERLY AND THE PATIENT EXPIRED. THE REPORTER OF THE EVENT CONFIRMS THE PATIENT'S FAMILY IS NOT RELEASING THE DEVICE. THE DEVICE IS NOT RETURNING FOR EVALUATION. THE MANUFACTURER BELIEVES THEY WILL BE UNABLE TO GATHER ADDITIONAL INFORMATION. THE MANUFACTURER IS SUBMITTING A FINAL REPORT AT THIS TIME. IF PERTINENT INFORMATION BECOMES AVAILABLE TO THE MANUFACTURER AT A LATER DATE, AN ADDENDUM TO THIS FINAL REPORT WILL BE FILED.

    Patient problems: Insufficient Information

    MAUDE report 12009571 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K102465. One submission often covers many models, so check the product and lot details in each record.

  • Z-1973-2021 · Jun 14, 2021 · Open, Classified
    DreamStation ASV, DreamStation ST, AVAPS, SystemOne ASV4, C-Series ASV, C-Series S/T and AVAPS, OmniLab Advanced+ Continuous Ventilator, Non-life Supporting The Philips Respironic

Other VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING devices

All VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page